Table 1 Comparison of characteristics between subjects with and without CKD (n = 560)
|  | CKD (n = 280) | Non-CKD (n = 280) | P value |
|---|---|---|---|
GFR (ml/min/1.73m2) | 54.03 (12.81) | 67.54 (6.45) | <0.001 |
Age (y) | 64 (12.50) | 63 (13.75) | 0.154 |
Sex (Male/Female) | 105/175 | 105/175 | – |
Duration of diabetes (y) | 11.99 (6.4) | 11.87 (4.72) | 0.417 |
Body mass index (kg/m2) | 28.72 (9.9) | 28.47 (3.88) | 0.554 |
Systolic blood pressure (mmHg) | 13 (3) | 13 (3) | 0.203 |
Diastolic blood pressure (mmHg) | 80 (18) | 79 (20) | 0.581 |
Use of anti-hypertensive drugs | 157 (56.5%) | 124 (44.9%) | 0.057 |
Fasting plasma glucose (mg/dl) | 143 (23) | 136 (38) | 0.078 |
2 h-PG (mg/dl) | 227.16 ± 89.431 | 209.09 ± 91.73 | 0.896 |
Use of glucose-lowering drugs | 201 (72.3%) | 207 (74.7%) | 0.510 |
Total cholesterol (mg/dl) | 184 (59) | 187.5 (41) | 0.702 |
HDL cholesterol (mg/dl) | 47 (12) | 46 (20) | 0.914 |
LDL cholesterol (mg/dl) | 102.8 (49) | 106.8 (43) | 0.426 |
Triglyceride (mg/dl) | 154.5 (124) | 148 (127) | 0.347 |
Use of lipid-lowering drugs | 125 (45%) | 112 (40.4%) | 0.459 |
Creatinine (mg/dl) | 1.2 (0) | 1 (0) | <0.001 |
FRAP (μmol/L) | 920 (252.5) | 1045 (217.5) | <0.001 |
Current or pervious smoking | 19 (6.8%) | 14 (5%) | 0.375 |
Hyperlipidemia | 48 (17.1%) | 47 (16.8%) | 0.514 |
Hypertension | 32 (11.4%) | 48 (17.1%) | 0.138 |
Obesity (BMI ≥ 30) | 103 (36.8%) | 104 (37.1%) | 0.986 |